Use of behavioural activation to manage pain: a systematic scoping review

Simple item page
dc.contributor.authorWalsh, S.
dc.contributor.authorMoseley, G.L.
dc.contributor.authorGray, R.J.
dc.contributor.authorGillam, M.
dc.contributor.authorGunn, K.M.
dc.contributor.authorBarker, T.
dc.contributor.authorTran, K.
dc.contributor.authorEshetie, T.
dc.contributor.authorJones, M.
dc.date.issued2022
dc.descriptionData source: Supplementary material, https://doi.org/10.1136/bmjopen-2021-056404
dc.description.abstractBackground: Behavioural activation (BA) is an effective treatment for depression; however, it is unclear if it can be used to manage pain. Objectives: To conduct a scoping review of primary research that reported using BA to support people living with chronic pain to understand how BA had been used in relation to pain. In addition, we wanted to understand whether there were any reported changes in that pain, and how and who delivered BA. Eligibility: criteria Primary research published in English. Sources of evidence: We searched seven databases MEDLINE, Ovid Embase, Ovid Emcare, PsycINFO, CINAHL, Scopus and Web of Science, for primary research. No initial date limit was used with the date the searches were conducted used as the end date limit (1 July 2021). Charting methods: A customised data extraction table was developed, piloted and used. Results: 551 papers were screened for inclusion, with 15 papers included in our review. Studies were conducted in North America and in Canada. These included three case studies, nine uncontrolled trials and three randomised controlled trials. Only two studies reported pain as the primary outcome. BA was applied across a range of pain related conditions. The dose of BA ranged from 3 to 16 sessions. Duration of treatment was 3 weeks to 12 months. Most studies reported reductions in pain following exposure to BA. Conclusion: BA has the potential to reduce pain. Caution needs to be exercised in the interpretation of these findings as a high risk of bias was observed in most studies. High-quality research is required to test if BA is an effective intervention for chronic pain.
dc.description.statementofresponsibilitySandra Walsh, G Lorimer Moseley, Richard John Gray, Marianne Gillam, Kate M. Gunn, Trevor Barker, Kham Tran, Tesfahun Eshetie, Martin Jones
dc.identifier.citationBMJ Open, 2022; 12(6):e056404-1-e056404-13
dc.identifier.doi10.1136/bmjopen-2021-056404
dc.identifier.issn2044-6055
dc.identifier.issn2044-6055
dc.identifier.orcidGunn, K.M. [0000-0003-0837-6814]
dc.identifier.urihttps://hdl.handle.net/2440/136174
dc.language.isoen
dc.publisherBMJ Journals
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1178444
dc.rights© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
dc.source.urihttps://doi.org/10.1136/bmjopen-2021-056404
dc.subjectHumans
dc.subjectTreatment Outcome
dc.subjectNorth America
dc.subjectCanada
dc.subjectChronic Pain
dc.subject.meshHumans
dc.subject.meshTreatment Outcome
dc.subject.meshNorth America
dc.subject.meshCanada
dc.subject.meshChronic Pain
dc.titleUse of behavioural activation to manage pain: a systematic scoping review
dc.typeJournal article
pubs.publication-statusPublished

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
hdl_136174.pdf
Size:
530.67 KB
Format:
Adobe Portable Document Format
Description:
Published version
Download

Collections

Medicine publications